LHC Group announced that its board of directors approved a share-repurchase program, allowing the company to repurchase up to $250 million of its common stock. LHC Group expects to fund the repurchase initiative through a combination of cash on hand, future cash flow and borrowings, reports Home Health Care News.
The share-repurchase program underscores LHC Group’s “continued commitment to building shareholder value” and reflects the board’s confidence in the company, Chairman and CEO Keith Myers said in a statement. Read more.
